Gene signatures and networks: linking COVID-19 to liver cirrhosis and hepatocellular carcinoma.

Gene signatures and networks: linking COVID-19 to liver cirrhosis and hepatocellular carcinoma.

Publication date: Dec 17, 2025

Open Access PDF

Concepts Keywords
Carcinoma Biomarker
Covid COVID-19
Hepatocellular Differentially expressed genes
Liver Hepatocellular carcinoma
Liver cirrhosis

Semantics

Type Source Name
disease MESH COVID-19
disease MESH liver cirrhosis
disease MESH hepatocellular carcinoma
pathway KEGG Hepatocellular carcinoma
pathway REACTOME Reproduction
disease MESH included
disease MESH Infectious Diseases
drug DRUGBANK Coenzyme M
drug DRUGBANK Huperzine B
drug DRUGBANK Saquinavir
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH fever
disease MESH nausea
disease MESH diarrhea
disease MESH injury
disease MESH ischemia
disease MESH cirrhosis
pathway REACTOME Immune System
disease MESH infection
disease MESH carcinoma
disease MESH cancer
disease MESH sepsis
drug DRUGBANK Trestolone
disease MESH preeclampsia
disease MESH hepatitis B
pathway KEGG Hepatitis B
disease MESH DSS
drug DRUGBANK Isoxaflutole

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *